WALTHAM, Mass.--(BUSINESS WIRE)--Avila Therapeutics, Inc. a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, announced that Katrine Bosley, Avila’s Chief Executive Officer, is scheduled to present a corporate update at the 31st Annual Cowen Healthcare Conference, on Monday, March 7, 2011 at 10:00 a.m. ET at the Boston Marriott Copley Place.
